prof. MUDr. Mgr. Marek Mráz, Ph.D.
Research Group Leader Senior, Marek Mráz Research Group
Office: bldg. E35/216
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8143 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 263
2020
-
The role of MYC in the transformation and aggressiveness of ?indolent? B-cell malignancies
LEUKEMIA & LYMPHOMA, year: 2020, volume: 61, edition: 3, DOI
2019
-
Analysis of Mutational Landscape in Systemic Anaplastic Large Cell Lymphoma Identifies Novel Prognostic Markers.
Year: 2019, type: Conference abstract
-
B Cell Receptor Signalling Regulation by Non-coding RNAs.
Year: 2019, type: Conference abstract
-
CD20 in the context of microenvironmental interactions of malignant B cells: Implications for targeted therapy.
Year: 2019, type: Conference abstract
-
Detection of a deletion at 22q11 locus involving ZNF280A/ZNF280B/PRAME/GGTLC2 in B-cell malignancies: simply a consequence of an immunoglobulin lambda light chain rearrangement
British journal of haematology, year: 2019, volume: 186, edition: 4, DOI
-
High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade During Ibrutinib Therapy in Patients with CLL.
Year: 2019, type: Conference abstract
-
High surface tumor IgM levels associate with reduced response duration and with BTK bypass during ibrutinib therapy in CLL patients
Year: 2019, type: Conference abstract
-
Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience
Leukemia Research, year: 2019, volume: 81, edition: JUN 2019, DOI
-
Jak vlastně fungují anti CD 20 monoklonální protilátky? Víme více po 20 letech jejich používání?
Year: 2019, type: Conference abstract
-
Komplexní mechanismy účinku inhibitorů „BCR signalizace“ a vzniku rezistence na tuto cílenou léčbu u chronické lymfocytární leukemie
Transfúze a hematologie dnes, year: 2019, volume: 25, edition: 4